E-Cigarettes Want Your Attention Now (Before the FDA Steps In)

Photograph by Christopher Furlong/Getty Images

The electronic cigarette is about to have its turn in the spotlight. The battery-powered gadgets transform nicotine and other substances into an inhaled vapor and have been marketed as a safer alternative to tobacco smoke, which is drawn into the lungs and increases cancer risks. The rapidly growing e-cigarette business—expected to top $1 billion in annual sales in the next few years—is racing to command a bigger share of spending among smokers and potential smokers ahead of possible regulations from the U.S. Food and Drug Administration.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.